A Study of Intra-operative Imaging in Women With Ovarian Cancer
- Conditions
- Ovarian CancerOvarian Carcinoma
- Interventions
- Diagnostic Test: Intravenous Indocyanine Green/ICG injectionDiagnostic Test: PINPOINT endoscopic fluorescence imaging systemDiagnostic Test: Endoscopy
- Registration Number
- NCT04878094
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
The purpose of this study is to find out whether using the PINPOINT imaging system intra-operatively can reduce the risk of anastomotic leaks and other complications after surgery for ovarian cancer, compared with standard intra-operative assessments alone. The PINPOINT endoscopic fluorescence imaging system uses a special camera and a fluorescent (glowing) dye that can evaluate the blood flow of the bowel in real-time. If there is an area that appears concerning, the surgeon can correct the problem during the procedure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 310
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm B Endoscopy Randomized to additional assessment of proximal colonic stump and anastomotic perfusion using NIR angiography Arm A Endoscopy Randomized to standard technique and assessment of anastomosis without the use of NIR angiography Arm B Intravenous Indocyanine Green/ICG injection Randomized to additional assessment of proximal colonic stump and anastomotic perfusion using NIR angiography Arm B PINPOINT endoscopic fluorescence imaging system Randomized to additional assessment of proximal colonic stump and anastomotic perfusion using NIR angiography
- Primary Outcome Measures
Name Time Method Reduction of the risk of 30-day postoperative anastomotic leak at the site of rectosigmoid resection, compared with standard intraoperative assessment alone 45 days post procedure To determine whether the use of NIR angiography assessment of perfusion at the time of rectosigmoid resection in a cohort of patients undergoing surgery for ovarian cancer reduces the risk of 30-day postoperative anastomotic leak at the site of rectosigmoid resection, compared with standard intraoperative assessment alone.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Memorial Sloan Kettering Westchester (Limited Protocol Activities)
🇺🇸Harrison, New York, United States
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
🇺🇸New York, New York, United States
Memorial Sloan Kettering Nassau (Limited Protocol Activities)
🇺🇸Uniondale, New York, United States
Jefferson Abington Hospital
🇺🇸Willow Grove, Pennsylvania, United States
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
🇺🇸Basking Ridge, New Jersey, United States
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)
🇺🇸Middletown, New Jersey, United States
Memorial Sloan Kettering Bergen (Limited Protocol Activities)
🇺🇸Montvale, New Jersey, United States
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities)
🇺🇸Commack, New York, United States